Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
Background: Psoriasis is a chronic, immune-mediated skin disease that may occur at any age. Prevalence in children ranges between 0.5 and 1.0% across Europe. Approximately 10-20% of paediatric psoriasis patients are moderate-to-severe in severity and may require the use of systemic therapy.Objective...
Saved in:
Main Authors: | Vito Di Lernia (Author), Laura Macca (Author), Lucia Peterle (Author), Ylenia Ingrasciotta (Author), Gianluca Trifirò (Author), Claudio Guarneri (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cobblestone-like skin
by: Laura Macca, et al.
Published: (2022) -
Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience
by: Federico Bardazzi, et al.
Published: (2017) -
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy
by: Ylenia Ingrasciotta, et al.
Published: (2021) -
Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
by: Di Lernia V, et al.
Published: (2016) -
Clinical evidence of therapy for genital psoriasis by biologic agents
by: Evgeny V. Sokolovskiy, et al.
Published: (2021)